24-26 March 2015; Johannesburg, South Africa
At AVAC's annual Partners' Forum, we share strategies and successes and set priorities for the future.
Each year, AVAC and a wide array of partners and allies gather to discuss the most urgent issues facing HIV prevention advocates. We share updates from country-level campaigns, look ahead to research results that may emerge in the next 12 months and identify priorities to tackle jointly and individually. It is a time to celebrate success and to re-commit to the work that remains to be done. This page includes images, presentations and video from Partners Forum 2015.
Voices from the Forum
- Partners' Forum Blog Posts
- Storify: Selected Tweets from the Meeting
- Closing Session Slides
- Partners' Forum Video
Agenda with Slides and Materials
Tuesday, 24 March
- HIV Px Research, Reality & Context: An Advocate's Perspective, Mitchell Warren, AVAC
- State of Advocacy: Unravelling and rebuilding—AIDS activism, rights and science then and now, Mark Heywood, Section 27
- State of the Science: What do we know now?, Linda-Gail Bekker, Desmond Tutu HIV Foundation
- State of the Response: Where advocacy and science meet, Chris Collins, UNAIDS
- Advocates’ Talk-back: Do intervention-specific targets help or hinder the HIV prevention agenda? A chance to digest the day’s plenaries
Wednesday, 25 March
Market Square: Shopping for new prevention options
Reflecting on the Future of Women's HIV Prevention Research
A group discussion to reflect on what we know and how we influence the way forward
Key Concepts for "Key Pops" Advocacy
How the concept helps, how it hurts, and what needs to happen next in the space of biomedical prevention and human rights?
Market Square: Shopping for insights into evolving science
Cutting Edge Science: What advocates need to know about passive immunization, antibodies and vaccines
Penny Moore, National Institute for Communicable Diseases
Holding Science Accountable: Entry points for research-focused advocacy
How do you advocate for concrete actions related to long-term research efforts? What kinds of short-term goals are relevant today?
- Engaging in Vaccine Development: Report-back from advocates’ participation in developing a pan-African vaccine science agenda
- Thailand’s National CAB: A structure for independent engagement in prevention research
- Breakout Sessions: Short-term milestones for research advocacy
Thursday, 26 March
- No time to turn back: The urgent action agenda for VMMC in 2015
- Women's bodies, choices and questions: The state of science and advocacy related to hormonal contraception and HIV
- From Proof-of-Concept to Prevention Phenomenon? Oral PrEP works when you take it—so what do we do now?
Special Strategy Session Led by African Partners
Group discussions to share experiences, strategies and tips
Signposts, Mile Markers, Potential Detours and More
Building the advocacy road atlas to Vancouver 2015; Durban 2016; 2020; 2030 and beyond
Meeting Wrap-up: Advocacy in Action